How much longer will tumour cells fool the immune system?

被引：39

作者：

Ferrone, S

Finerty, JF

Jaffee, EM

Nabel, GJ

机构：

[1] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA

[2] NCI, Canc Immunol & Hematol Branch, Rockville, MD 20852 USA

[3] Johns Hopkins Univ, Sch Med, Dept Oncol & Immunol, Baltimore, MD 21205 USA

[4] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA

来源：

IMMUNOLOGY TODAY | 2000年 / 21卷 / 02期

关键词：

D O I：

10.1016/S0167-5699(99)01569-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In spite of successful control of tumour growth in mice; immunotherapy has yielded disappointing results in patients with malignant diseases; A recent meeting* focused on the mechanisms used by tumours to escape immune recognition and the implications for cancer immunotherapy.

引用

收藏

页码：70 / 72

页数：3

相关论文

共 8 条

[1]

Chappell DB, 1999, CANCER RES, V59, P59

[2] Regulation of the proinflammatory effects of Fas ligand (CD95L) [J].

Chen, JJ ;

Sun, YN ;

Nabel, GJ .

SCIENCE, 1998, 282 (5394) :1714-1717

[3]

GASTMAN BR, IN PRESS CANC RES

[4] Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape [J].

Hahne, M ;

Rimoldi, D ;

Schroter, M ;

Romero, P ;

Schreier, M ;

French, LE ;

Schneider, P ;

Bornand, T ;

Fontana, A ;

Lienard, D ;

Cerottini, JC ;

Tschopp, J .

SCIENCE, 1996, 274 (5291) :1363-1366

[5] HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story [J].

Hicklin, DJ ;

Marincola, FM ;

Ferrone, S .

MOLECULAR MEDICINE TODAY, 1999, 5 (04) :178-186

[6] Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients [J].

Lee, PP ;

Yee, C ;

Savage, PA ;

Fong, L ;

Brockstedt, D ;

Weber, JS ;

Johnson, D ;

Swetter, S ;

Thompson, J ;

Greenberg, PD ;

Roederer, M ;

Davis, MM .

NATURE MEDICINE, 1999, 5 (06) :677-685

[7]

MARINCOLA FM, IN PRESS ADV IMMUNOL

[8] Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation [J].

van Elsas, A ;

Hurwitz, AA ;

Allison, JP .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (03) :355-366